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From the Editor: ACP, SDM & Sustainability
In this issue, readers will notice the frequent appearance 
of advance care planning as the theme of community 
involvement, education of elders and preparing for 
end-of-life (EOL). Advance care planning has been 
emphasized as a process of communication regarding 
end-of-life care options. The notion of a bilateral 
communication process in health care is not new. In 1997, 
Charles et al published a paper titled “Shared 
decision-making in the medical encounter: What does it 
mean? (or it takes at least two to tango)”, which has been 
cited extensively by now.1 The authors described the key 
characteristics of shared decision-making (SDM) (1) it 
involves at least two participants—physician and patient; 
(2) both share information; (3) both take steps to build a 
consensus about the preferred treatment; and (4) that an 
agreement is reached on the treatment to implement. SDM 
has been advocated as an ideal model in medical treatment 
decision-making in medical encounters with patient- 
centered care as the ultimate goal. 
SDM rests on the best evidence of the risks and benefits 
of the available options with different possible outcomes and 
substantial uncertainty. The process include ensuring 
patients’ understanding of information, eliciting patients' 
preferences, sharing treatment recommendations, and 
making explicit the component of uncertainty in the clinical 
decision-making process.2 There are now a large number of 
patient decision programs (decision aids) available and their 
use has been evaluated in randomised controlled trials. A 
Cochrane review has summarised the findings from 55 trials 
and found that use of patient decision aids led to: 3
■ greater knowledge 
■ more accurate risk perceptions 
■ greater comfort with decisions 
■ greater participation in decision-making 
■ fewer people remaining undecided 
■ no increase in anxiety 
■ fewer patients choosing major surgery
SDM has been regarded as "The Greatest Untapped 
Resource in Healthcare” in the Salzburg Global Seminar 
held in December 2010, and following that, the Salzburg 
statement on shared decision-making was published in BMJ 
in 2011 to stimulate attention.4 Ethically, patients should be 
involved more in decisions about their own medical care and 
the risks involved; practically it brings down costs through 
careful presentation of information and the use of decision 
aids/pathways. Unwarranted practice variations, but with 
no better outcomes, are reduced. SDM is therefore being 
promoted to deliver sustainable health care through patient 
centred care and patient empowerment. In UK, the National 
Shared Decision Making programme, led by NHS East of 
England, is designed to promote patient centred care and to 
enhance sustainability of care and the paper "Making 
Shared Decision-Making a Reality.  No decision about me, 
without me" was published recently.5
If SDM is so good to adopt, why has it not become as 
popular as it should be? In a systematic review of 28 studies 
on the barriers and facilitators to SDM in health care 
professionals, the three most often reported barriers were 
time constraints, lack of applicability due to patient 
characteristics and lack of applicability due to the clinical 
situation. The three most often reported facilitators were 
provider motivation, positive impact on the clinical process, 
and positive impact on patient outcomes.6
By now, readers would appreciate the similarity in the 
components of SDM and advance care planning (ACP). In 
SDM, the context is often related to treatment of life 
threatening illness or chronic diseases7; in ACP, it is about 
the preferred care at EOL. There is no obvious reason why 
barrier to ACP is less than that for SDM, as preparing for 
end-of-life is about overcoming barrier to discuss death and 
dying. Such barrier exists in the professionals, who often 
feel uncomfortable to address the apparent failing of 
medicine, and in patients, who are often not prepared to face 
the unknown of the dying phase.     
The modern hospice movement as initiated by Dame 
Cicely Saunders is now more than 30 years on. While 
palliative care has flourished in many parts of the world 
since then, there are endless challenges to ensure the 
sustainability of palliative care development. From the 
English dictionary, to “sustain" means to keep in existence; 
to supply with necessities or nourishment; to support from 
below to keep from falling or sinking; to support the spirits, 
vitality and to encourage; to endure; to experience or suffer; 
to prove and confirm and to maintain competence. All these 
elements are not just essential to uphold the quality of 
palliative care, but also the health care system and the 
society. 
Modern health care systems have been undergoing 
reforms to achieve sustainability. However, this would not 
be possible without reflections and critical evaluations. Data 
collection, not just on the volume and coverage, but also the 
outcomes has to be considered seriously. Inconsistency and 
lacking of clear concept or definition of a care model pose 
hurdles for critical analysis, such as the case of SDM, a term 
which has been used inconsistently in some reasearch 
papers.8 It is encouraging to see growing attention to 
advance care planning in Hong Kong. However, there are 
many challenges ahead. It remains for palliative care 
professionals to define the structured components of the 
advance care planning process, the indicators of the 
processes and the outcomes. Critical evaluation of ACP 
sheds light on the sustainability of the palliative care 
development and also our health care system. 
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Report on 
The Symposium was held on 20 August 2011 at Hui Pun Hing 
Lecture Hall, The University of Hong Kong.  The lecture hall 
was packed with enthusiastic faces. More than 300 healthcare 
professionals from various clinical settings attended.  The 
program began with, on behalf of the 
organizing committee, Dr. Chan 
Kin-sang’s warm welcome to all 
participants.  We are honored to 
have Dr. Leung Pak-yin, Chief 
Executive of the Hospital Authority as our Guest of 
Honor for the opening ceremony.  He made an 
encouraging speech sharing his insight on 
end-of-life care from a healthcare management 
expert’s perspective. 
Report on 8th Hong Kong Palliative Care Symposium
8th Hong Kong Palliative Care Symposium
Dr. Chan Kin-sang, 
    Chair of Organising Committee
Dr. Leung Pak-yin,
Chief Executive, HA Left to right:
Dr. Chan Kin-sang,
Dr. Leung Pak-yin,
Prof. Cecilia Chan 
More than 20 guest 
speakers were invited for the 
Symposium. The major themes of the Symposium include 
new challenges in palliative care: ”Prognostic challenges 
for palliative care” was shared by Dr. Lam Po-tin, 
“Reﬂection on palliative care for advanced cancer patients 
in the age of targeted therapy” by Dr. Rebecca Yeung, as 
well as “Ethical dilemma for tube feeding in advanced 
dementia patients” by Prof Samantha Pang. The session 
was very stimulating and called for our reﬂections.  
Moreover, the theme on Grief and bereavement were 
shared by Dr. Celia Chan and Dr. Amy Chow on “Perinatal 
bereavement: Grieving pregnancy loss in miscarriage and 
stillbirth” and “Intervention model with older adults 
coping with grief & loneliness” respectively. 
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Honorable guests & organizers
We were pleased to have received a record high of abstract 
submissions for the freepapers session. It was a tough task for 
the adjudicators, Dr. Wong Kam-hung, Dr. Rico Liu and Ms. 
Leung Man Wai to select the two outstanding awards from 
13 contestants.  Congratulations to Dr. Poon Yin of CMC 
and Ms. Theresa Lai of PMH.
Besides the free-papers, there were three other 
afternoon concurrent sessions, all with a unique 
perspective. “Volunteer work for end-of-life care services” was 
a theme discussed, where “Volunteers in supporting the dying in hospital” was shared by Ms. Ellen 
Yeung and RH-TSKH volunteers. A drama on Advance Care Planning was performed by 3G Alumni of 
SPHC to prelude the sharing of “Engaging volunteers in community outreach program on Advance 
Care Planning” by Ms. Carol Cheng and Ms. Betty Fung.  “New Challenges for Palliative Nursing” is 
the theme for the nurses’ session.  Cases on “Non-cancer end-of-life care” were shared by Ms. Cecilia 
Kwan, Ms. Chiu Pui Chi, Ms. Kwan Yuen Fan, Ms. Mak Kit Nga, while “Advance Care Planning” was 
shared by Ms. Chan Chun Hung. There was also a workshop conducted by Dr. Rhoda Yuen on 
“Spiritual care at the end of life”. 
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Dr. Rico Liu & Dr. Poon Yin, awardee of 
outstanding presentation in Free Paper Session
Dr. Wong Kam-hung & Ms Theresa Lai, awardee of 
outstanding presentation in Free Paper Session
Ethical dilemma for tube feeding in advanced dementia patients
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Eating problems commonly present during the final stage of 
dementia. Either placing a feeding tube or forgoing the tube in this 
population poses ethical dilemma to care providers. On one hand, 
tube feeding is a common approach despite consistent clinical review 
reports found no demonstrable benefits in terms of key outcomes 
such as prolonged survival or improved nutritional markers. On the 
other hand, marked variation in tube feeding exists across different 
places. Studies on places with high and low tube feeding practices 
varied in their institutional values, health professional values, physical 
environment, care processes for feeding, and decision making 
approaches. Forgoing tube feeding is controversial from an 
ethical-clinical viewpoint. It can deliver sufficient nutrition and 
hydration to support the patient’s life hence a basic sustenance care 
which should always be in place; yet it fails to improve the underlying 
incapacitating condition which put into question its medical benefit. 
Such decision-making would inevitably be value-based and emotionally-laden. 
Before whatever else we should do no harm to others is the 
ethical mandate that care providers are obliged to observe in 
service provision, yet what counts as harm to others in a 
pluralistic community where people do not agree on the same 
set of fundamental values yield competing clinical implications. 
From the human rights perspective, care providers who fail to 
respect the patient’s rights would count as harm. Drawing on the 
duty-driven dignitarian view, an act that compromises human 
dignity would count as harm. An act is right if it can maximize 
health and happiness from a utilitarian perspective, hence harm 
to others would be performing an act which its negative 
consequence outweighs the positive consequence. Given the 
disagreement on these fundamental values, the possibility of 
resolving the conflicting views on tube feeding or not patients with 
advanced dementia would be remote. In this presentation, I will take a virtue ethics perspective to examine the 
possibility of agreement of what 
counts as good and harm in tube 
feeding decision making, 
focusing on the telos (or ends) of 
the care provider and patient 
relationship.
Prof. Samantha PANG
Professor and Head, School of Nursing, The Hong Kong Polytechnic University
Challenges in palliative care
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Panel discussion: (From Left to right) 
Dr. Doris Tse, Dr. PT Lam, 
Dr. Rebecca Yeung, 
Prof Samantha Pang, 
Prof. Cecilia Chan
Prof Samantha Pang & Prof. Cecilia Chan
Prof Samantha Pang & Dr. PY Leung, CE, HA
Many couples have experienced the death of a 
baby. It could happen during pregnancy, during 
delivery, shortly after birth, or during infancy. Some 
are unexpected: in spite of medical advances, more 
than one-fifth of all expectant parents will at some 
time experience miscarriage, stillbirth or infant 
death. For some other couples, early termination, 
whether of unwanted pregnancies due to personal 
choice or of wanted pregnancies due to medical 
reasons, is carried out at their own decision.
A couple’s experience of loss in miscarriage and 
stillbirth is not easily shared by others – “but it 
wasn’t even a baby yet.” The lack of clarity of the 
loss (in the absence of a touchable, separate 
infant’s body) is the reason for many who find it 
difficult to appreciate the full extent of grief in 
pregnancy loss. Couples who have miscarriage and 
stillbirth are also confused about their bereavement 
experience and sometimes not sure about how to 
react. As a result, many of them choose not to seek 
help and support from their family and friends; the 
couple does not know how to name the grief, 
neither do those who are close to them know how to 
respond.
In Chinese societies, expectant mothers do not 
disclose their pregnancy during the first trimester for 
the traditional fear that it would jinx or ‘upset’ the 
baby, who would then ‘refuse to be born’. 
Pregnancy loss during this early stage, while not 
uncommon, will be a secret within a secret, further 
complicating the grief process.
In essence, pregnancy loss due to miscarriage 
or stillbirth is always considered as disenfranchised 
grief over an ambiguous loss. Cultural 
considerations are important in helping the Chinese 
couples who are facing the losses. 
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Dr. Celia Chan at her presentation
Grief and Bereavement
Dr. Celia CHAN H.Y.
Teaching Consultant, Centre on Behavioral Health
Honorary Lecturer, Department of Social Work and Social Administration,
The University of Hong Kong
Perinatal bereavement: Grieving pregnancy loss in miscarriage and stillbirth
Panel discussion: (From left to right) Ms Leung Man Wai, 
Dr. Annie Kwok, Dr. Amy Chow, Dr. Celia Chan
End-of-life care for 
non-cancer patients
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Current development of palliative care has 
extended to patients with advance diseases other 
than cancer. Patients with organs failure like end 
stage renal disease (ESRD), chronic obstructive 
pulmonary disease (COPD), heart failure, and even 
dementia and stroke are relatively new to palliative 
care nurses. To take good care of these types of 
patients and to ensure effective symptom control and 
end-of-life support is a challenge for many nurses who  
used to look after terminal cancer patients.
These patients present with symptoms not exactly 
like those of cancer patients. End stage chronic kidney 
disease patients without dialysis present a number of 
physical symptoms like edema, pain, nausea and 
vomiting, bowel and bladder problems, lethargy, 
dyspnoea and pruritus. Patients with chronic liver 
disease present with severe pain, pruritus, ascites, 
hepatic encephalopathy and sometimes variceal 
hemorrhage. COPD patients might suffer much from  
dyspnoea, fatigue and cachexia. The causations of 
these symptoms are different requiring different way 
of interventions and nursing support. The use of drugs 
to relieve pain, edema, nausea and vomiting are 
considered differently from those for cancer patients. 
The associated nursing observation and support 
requires adjustment. 
The psychological, social and spiritual needs of 
these patients are no less than cancer patients. 
Feelings of depression, social isolation, and burden to 
family are common among patients at end-of-life 
stage no matter what the diseases are. The holistic 
approach of palliative nursing renders important 
support to these patients. However, the disease 
trajectories may vary among these terminal illnesses. 
Advanced cancer and ESRD patients may present 
with slow deterioration while patient with heart failure 
might risk a sudden death. All these have impact on 
the fine tuning of the approach of care. The discussion 
on disease progression, advance care planning and 
reassurance of continual support formulate important 
element of nursing interventions. 
New Challenges for Palliative Nursing 
Ms. Cecilia KWAN, 
Ward Manager, Bradbury Hospice
Ms. CHIU Pui-chi, Ms. MAK Kit-nga, 
Advanced Practice Nurses, Haven of Hope Hospital
Ms. Piana KWAN Y.F., 
Registered Nurse, Bradbury Hospice & Shatin Hospital
New challenges for palliative nursing
Advance care planning (ACP) is 
the process of planning for future 
medical care, particularly for the 
event when the patient is unable to 
make his or her own decisions. 
During this process patients explore, 
discuss, articulate, and document 
their preferences. The process helps 
patients to identify and clarify their 
personal values and goals about 
health and medical treatment. They 
identify the care they would like, or 
not like, to receive in various 
situations.
The model for ACP can be applied to other 
decision-making processes as patients plan for the 
end of their lives (e.g., planning for bequests, 
autopsy, burial / cremation, funeral/ 
memorial services, guardianship, choices 
of caregivers, and settings for care).
It is helpful to think of the process as a 
stepwise approach. The steps include the 
appropriate introduction of the topic, 
structured discussions covering potential 
scenarios, documentation of preferences, 
periodic review and update of the plans 
and directives, and application of the 
wishes when needed. The steps can then 
be flexibly integrated into routine clinical 
encounters by the members of the health 
care team. The process fosters personal resolution 
for the patient, preparedness for the carer, and 
effective teamwork for the professionals.
Advance Care Planning Ms. Red CHAN C.H., 
Advanced Practice Nurse, Tuen Mun Hospital
Volunteers in supporting the dying in hospital
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Ms. Ellen YEUNG Wai-fong 
Hong Kong Palliative Nursing Association
Palliative Nurse Specialist, 
Ruttonjee & Tang Shiu Kin Hospitals
Engaging volunteers in community outreach program on advance care planning
Volunteer Work for End-of-life Services 
Volunteer work for end-of-life services
Volunteers have always been the core of any palliative program. 
They generously offer their time talents and energy. They offer 
terminally ill patients and their families comfort, support, and 
companionship. Palliative volunteers are important members of 
an interdisciplinary team, serving to “de-institutionalize” the 
dying experience and provide a more humane system of care for 
the dying and their families. Palliative volunteers have 
challenging jobs, which may include hospital and home visits, 
family care, administrative support, help with day programs, 
special events and celebrations, bereavement support 
and the list goes on. Each person brings a unique mix of 
talents and interests to the palliative experience and 
each volunteer is needed and appreciated by everyone 
in the palliative community. Volunteers in palliative 
setting find it personally gratifying, intellectually 
stimulating, and emotionally meaningful to assist those 
in need at a critical point in their lives. Many of these 
volunteers were introduced to palliative services through 
the death of a family member and understand firsthand 
the value of palliative care. Volunteers consistently 
report that helping the terminally ill is not about dying but 
about living and they find that it brings meaning and 
purpose to their lives.
 
Ms. Carol CHENG Chit-yan
Education Officer, Society for the Promotion of Hospice Care
Ms. Betty FUNG Pei-tai
Community Education Officer, 
Society for the Promotion of Hospice Care
Advance Care Planning (ACP) is a process of improved 
understanding, reflection, and discussion to create a clear 
plan, formulated in advance to guide medical and health 
care decisions if the ill person is unable to make decisions. 
This process takes into account the person’s health 
condition, culture, relationships as well as his or her goals 
and values. ACP is a complicated but useful process to 
empower people to plan proactively for an improved quality 
end-of-life care.
Ms. Ellen YEUNG Wai-fong & Mrs Yvonne Siu
Workshop participants in small group discussion
Mrs Yvonne Siu, Ms Carol Cheng & Betty Fung
Sponsored by Lee Hysan Foundation, the ACP project aims to support older adults in the community to 
actualise ACP in a systematic manner and territory-wide outreach. In 2008-2011, ACP project reached over 
2,000 elders, family members, volunteers and care workers. In this project, the role of volunteers is significant. 
The volunteer management strategy can help in effective operation which includes planning, recruitment, 
training, supervision and recognition. The components are playing its integral functions to make a successful 
volunteer teamwork possible. 
相也
安未 到 生死
Evaluation of the Responsiveness of Goal 
Attainment Scaling in the Measurement of 
Oncology In-Patients under Physiotherapy 
Treatment
LIU Yuet-ming*, M.Y.C. PANG
*Physiotherapist I, Physiotherapy Department, 
Princess Margaret Hospital
Background 
There is a lack of a responsive evaluation tool for 
measuring the progress of the frail oncology inpatients 
undergoing physiotherapy intervention. Although 
Barthel Index (BI) has been used, its responsiveness 
has been challenged.
Objective
1) to assess the inter-rater reliability and 
responsiveness of Goal attainment scaling (GAS) in 
oncology inpatients who were undergoing 
physiotherapy    
2) to compare the responsiveness of GAS with BI.
Method
A total of 38 oncology inpatients (22 men and 16 
women), with mean age ± SD =65.63 ± 13.75 were 
recruited. They were scored with GAS and BI before 
and after completing 3-day of physiotherapy 
intervention. 10 subjects were randomly selected to 
receive another post-treatment scoring for the 
establishment of inter-rater reliability. The pre-test and 
post-test scores of GAS (T-score) and BI were 
compared by using paired t-tests. Effect sizes (ES), 
standardized response means (SRM) were used to 
determine the responsiveness while relative efficiency 
(RF) between GAS and BI was used to compare their 
responsiveness.
Results
High inter-rater reliability were reflected in the ICC 
(2,1) = 0.98. Moreover, ES (1.51), SRM (0.87), and RE 
(214) of GAS were significantly greater than the 
corresponding values of BI (ES=0.04, SRM=0.06, 
RE=1). After 3 days of physiotherapy treatment, GAS 
score (p <0.001, 95% Confidence interval = 5.74 -14.34) 
was significantly increased, but not BI (p=0.75, 95% 
confidence interval = 4.93 - 6.79). 
Conclusion 
The results showed that the GAS has high inter-rater 
reliability and it shows better responsiveness than BI. 
GAS is thus a useful tool for measuring changes in 
functional outcomes in oncology inpatients.
Health Care Staff’s Perception of End-of-life Care 
in a Local Adult Intensive Care Unit
Jasmine CHAN T.M.*, K.L. LEE
*Resident Specialist, Department of Medicine & 
Geriatrics, United Christian Hospital
Background
Death in the Intensive Care Unit (ICU) is often 
inevitable. Nowadays, more emphasis is given on 
improving the care of dying patients and their families 
in ICU. Better understanding of health care staff’s 
perception of end-of-life (EOL) care could facilitate its 
development in the future.
Objective
To examine the perception of medical and nursing staff 
who work in an adult Intensive Care Unit of a regional 
hospital on end-of-life care.
Method
This is a cross-sectional questionnaire survey. Health 
care staff’s perception was assessed over 5 domains of 
quality end-of-life care in ICU setting. 
Results
A total of 78 questionnaires were sent, the response 
rate was 70%. Majority of the respondents agreed 
(65%) that life-sustaining treatment is forgone in a way 
that patient or family’s preferences are respected. Two 
third of the respondents also agreed that decision 
within the health care team is clearly communicated 
with patient or family. However, only 38% thought 
that they are confident in handling conflicts or intense 
emotions of the patient and family. It is associated with 
training in EOL care (p < 0.05) but not duration of ICU 
experience. Although 64% respondents felt competent 
in advising comfort care and symptom management, 
they admitted that it is psychologically more 
comfortable to withhold than withdraw life-sustaining 
treatment. Among the domains of quality EOL care, 
communication was ranked as the most important 
area. 
Conclusion
End-of-life care is given attention in the Intensive Care 
Unit. More training and education on this 
management aspect is warrant, particularly to enhance 
psychological care and communication skill of health 
care staff.
Cross Sectional Study on the Desire for Hastened 
Death among Hong Kong Chinese Patients with 
Advanced Cancer in an Acute Hospital
CHEUNG Wai-yin*
*Resident Specialist, Department of Medicine & 
Geriatrics, United Christian Hospital
Background 
Being a common phenomenon in the palliative care 
setting, the desire for hastened death (DHD) among 
patients with advanced cancer has not been studied in 
Hong Kong.
Objective 
This cross-sectional study serves to investigate the 
prevalence and the correlates of DHD in Chinese 
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patients with advanced cancer in an acute regional 
hospital.
Method
Standardized measurement tools including the Desire 
for Death Rating Scale (DDRS), Hospital Anxiety and 
Depression Scale, Herth Hope Index, Memorial 
Symptom Assessment Scale and Norbeck Social 
Support Questionnaire were used to assess consenting 
participants.
Results
High DHD was reported in 38% of subjects. Strong 
correlation was shown between DDRS scores and 
markers of depression, hopelessness and physical 
symptom distress. Patients with tertiary education or 
above also reported significantly higher DHD. By 
logistic regression, depression and hopelessness were 
shown to be predictive of high DHD.
Conclusion
The desire for hastened death in advanced cancer 
patients is significantly correlated with depression, 
hopelessness and physical symptom distress. Further 
studies are needed to investigate on the mechanisms 
and possible rooms for the intervention of these factors 
in managing DHD of Chinese cancer patients.
Systems Dynamics in the Community Care 
Pathway at the End-of-Life:: the Hong Kong 
Experience
Michelle TAM Y.J.*, C.L.W. CHAN, J.K.H. LUK, 
F.H.W. CHAN, C.W.K. CHAN, 
C.H.C. FONG, A.H.Y. HO, C.K.K. KWOK, W.C. NG, 
J.H.L. YUEN
*Research Coordinator, Centre on Behavioral Health, 
the University of Hong Kong
Background
Since 2009, the HKWC-CGAT in collaboration with 
TWGHs JC C&A Home piloted the “EOL Program for 
RCHE in HKWC” program. The program offered 2 
EoL care pathways on top of existing care framework: 
1) AED pathway: residents remain in RCHE during 
last stage of life and stay there until very last moment 
of life; 2) FYKH pathway: resident be transferred to the 
hospital via expedite pathway at the last moment of 
life to receive hospice and palliative care until he/she 
passed away. The program has served 32 residents, 9 
have chosen the AED pathway and two passed away 
peacefully in 2010. Success of this program highlights 
the need to examine interplaying factors in EoL care 
pathway and reflect on practical implications for 
quality EoL care. 
Objective
To identify system factors that contributes to EoL care 
decision making and dignified EoL Care Pathways. 
Method 
This is a qualitative study with individual interviews 
and focus groups conducted. Participants was 
purposively sampled, focusing on key participants in 
the EoL program: residents who participated in the 
scheme; family members; medical and allied-health 
staff; and administrative staff. 
Results
Prelimary findings revealed themes that affect 
implementation of the EoL program: 1) information 
about the EoL program; 2) trust between family 
members and healthcare system; 3) readiness of RCHE 
staff; and 4) communication between the different 
parties. 
Conclusion 
Comprehensive EoL care should address needs of 
multiple parties operating at different levels. Trust and 
communication within the system is key to a successful 
EoL care pathway. 
The End-of-life Profile of Advanced Cancer 
Patients in a Palliative Care Unit: Highlights 
from the End-of-life Care Pathway
POON Yin*, D.M.W. TSE, K.H. NG, O.L. KWOK, 
M.H. KHEMLANI, K.W. WOO, W.S. YAU
*Resident, Palliative Care Unit, Caritas Medical 
Centre
Background
A modified end-of-life (EOL) care pathway based on 
the Liverpool Care Pathway for the dying (LCP) - 
Multidisciplinary Team End of Life Care Pathway 
(MDTEOLCP) was launched in Palliative Care Unit 
(PCU) of Caritas Medical Centre (CMC) since 2010. It is 
used as a guide to provide care and support for the 
dying and caregivers.
Objective
To assess the symptoms, medication profile, and the 
psycho-spiritual needs of patients and caregivers at 
EOL. 
Method 
This is a retrospective chart review of patients who 
died in PCU of CMC with implementation of 
MDTEOLCP from 1st June, 2010 to 31st March, 2011. 
Descriptive statistics was used to assess the prevalence 
of symptoms, medication pattern, and psychosocial 
and spiritual needs. 
Results 
A total of 109 patients were analysed, among which 
76% died within 72 hours of initiation of MDTEOLCP. 
The physical symptoms profile as documented in the 
MDTEOLCP included urinary problems (87%), 
cachexia (68%), dyspnoea (59%), death rattle (37%) and 
pain (24%). The most commonly drugs that were 
prescribed preemptively included analgesics (72%), 
antipyretic (31%) and haloperidol (19%); whereas the 
most commonly used drugs were oxygen (91%), 
analgesics (72%), hyoscine butylbromide (39%), 
antipyretic (25%) and haloperidol (24%). Five patients 
were given palliative sedation. There was rapid 
declineof food intake and conscious level from 72 
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hours before death, but with no associated increase in 
Ryle’s tube insertion. Family members were 
interviewed by medical social worker in 49% of 
patients within last week. Urgent referral for 
psychosocial interventions was initiated in 7 patients. 
In 52% of patients, family had ever stayed overnight 
and in 65%, family was present at death. 
Conclusion 
Advanced cancer patients had considerable symptoms 
at EOL, with dyspnoea more prevalent than pain. The 
medications used may guide the preemptive 
prescription in facilitating timely symptom control. 
The EOL care pathway can provide a database to 
reflect the profile and needs of the dying patients. 
An Audit of the End-of-life Care Pathway in a 
Non-cancer Palliative Care Setting
Tracy CHEN W.T.*, W.M. WONG, C.K. MOK
*Associate Consultant, Department of Medicine & 
Geriatrics, Tuen Mun Hospital
Background 
Majority of deaths in Hong Kong occur in public 
hospital. Chronic non-cancer illnesses account for most 
of the deaths. An End-of-life Care Pathway (ECP) 
based on the recommendation in Liverpool Care 
Pathway for Dying Patient (LCP version 12) was 
developed. It was the first ECP applied to non-cancer 
setting in the M&G Department TMH.
Objective
To evaluate the standard of care for dying patients and 
to benchmark our performance with the National Care 
of the Dying Audit – Hospital (NCDAH) 2009 in UK.
Method
The pilot of ECP in the non-cancer palliative care unit 
TMH began at 1st Aug 2010. A retrospective audit was 
done to gather the ECP data from 1st August to 31st 
December 2010. Standard of care for dying patients 
was developed based on the latest version of LCP. 
Comparison of the ECP with NCDAH 2009 was made 
to evaluate the standard of care in our unit.
Results
A total of 117 deaths occurred in the audit period and 
42 ECP was applied (34%). The median duration in 
ECP is 62 hours (IQR = 18 – 103). The results were 
compared with NCDAH 2009. Higher percentage of 
overall achievement was noted in our ECP. The 
average percentage of achievement was 86.6% in ECP 
vs 58.7% in NCDAH 2009.
Conclusion
The use of ECP provides a foundation for good 
symptom control, spiritual, psychological, social and 
spiritual support. Higher percentage of achievement 
was noted in most areas compared with NCDAH. 
Continuous staff education and supervision are 
required to further improve the ECP recruitment rate 
and performance in those weaker areas.
Symptom Profile and Control in Patients with 
Advanced Pulmonary Diseases Receiving 
Palliative Care
Jeffrey NG S.C.*
*Resident Specialist, Pulmonary and Palliative Care 
Unit, Haven of Hope Hospital
Objective
This retrospective study aims to review the symptom 
profile of the patients with advanced pulmonary 
diseases referred to a palliative care program, and the 
control of symptoms upon follow-up. 
Method
Patients with clinical evidence of severe pulmonary 
diseases were referred for the program. They were 
routinely assessed in the first two palliative 
consultations for symptom profile with a checklist of 
sixteen symptoms and an extra free-entry item, using 
categorical scale (none, mild, moderate or severe). The 
single most distressing symptoms were recorded. 
Improvement was defined as a shift in symptom scale 
upon the second assessment.
Results
From July 2010 to April 2011, totally 75 patients were 
recruited. There were more male (82.7%) patients, of 
mean age 77.2 and median palliative performance scale 
(PPS) of 60%. Thirty-seven patients (49.3%) died, with 
mean length of service being 92.6 days. There were 55 
patients who completed the first assessment, and 40 
successfully did the second. The majority (90.7%) had a 
primary diagnosis of chronic obstructive pulmonary 
disease.
The most distressing symptom was dyspnoea (70%), 
followed by dry mouth (10%), pain (6%) and insomnia 
(6%). The control of these symptoms was reported: 
dyspnoea (17.6% improved, 67.6% static), dry mouth 
(36.7% improved, 56.7% static), pain (42.9% improved, 
47.6% static) and insomnia (43.5% improved, 39.1% 
static). The most prevalent symptoms were dyspnoea 
(87.5%), tiredness (76.8%), dry mouth (73.2%), cough 
(60.7%), insomnia (53.6%), pain (50%) and urinary 
disturbance (50%).
Conclusion
Symptoms prevalence is high in patients with 
advanced pulmonary diseases. Our findings suggest 
that active palliative intervention can be effective in 
symptom control for these patients.
Quality of Life among Hong Kong Chinese 
Patients with Malignant Brain Tumour during 
the End of Life Phases
Josephine Cheung M.Y.*, V.Y.H. TANG, S.K.S. NG, 
C.K.Y. LAU, D.T.M. CHAN, W.S. POON
*Psychologist Assistant, Department of Surgery, 
Neurosurgery, The Chinese University of Hong Kong
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Background 
Handling dreadful news with patients who have 
advanced malignant brain tumour is not ever easy or 
straightforward. Standard treatment consists of 
surgery, radiotherapy, with or without 
chemotherapy, yet the treatment outcome and 
prognosis are not promising in terms of extending life 
expectancy. Patients and significant others are 
overwhelmed by uncertainties, as well as the issues of 
death and dying. They are generally under an 
enormous level of distress and discomfort which may 
have an impact on their quality of life (QoL).
Objective 
This study focused on examining the quality of life in 
a clinical setting for advanced malignant brain 
tumour patients during their end of life phases. The 
measures assessed physical, social, emotional, role 
and cognitive functioning among patients.
Method 
Standardized questionnaires of the European 
Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire, Core 30 and Brain 
Cancer 20 module (ECORTC QLQ – C30 and QLQ – 
BN20) were employed. Twelve patients (mean age of 
onset 47; 7 males and 5 females) diagnosed with 
malignant brain tumours were recruited at the Prince 
of Wales Hospital during the phases of (i) pre and post 
operational treatment (n = 9), (ii) pre and post 
concomitant chemo-radiotherapy (n = 6), and (iii) pre 
and post radiotherapy alone (n = 4).
Results 
The global quality of life remained rather stable 
throughout the different phrases, and no significant 
difference was evident. However after the 
concomitant chemo-radiotherapy, patients had 
significant improvement in social functioning (p = 
.015, η2 = .72) and reported a significant decrease of 
physical pain (p = .045, η2 = .46). For those who 
received radiotherapy alone, the decrease in the 
subjective report of physical pain also reached a 
marginal significance level (p = .058, η2 = .75). This 
could be interpreted as a trend for positive 
improvement.
Conclusion 
This study showed preliminary findings on patient’s 
quality of life throughout the end of life phases among 
the group of malignant brain tumour patients. 
Focusing on the medication such as pain relief, 
providing proper psychological counseling, 
encouraging social life among family members and 
instructing stress management skills could enhance 
and facilitate the true meaning of “active living”. 
Searching for Spiritual Peace: 
A Case Example of Life Integration and 
Relationship Reconciliation in the End-of-Life
Pearl TSE M.Y.1, Candy FONG H.C.2, P.P.Y. LEUNG, 
P.O.K. NG, J. LEUNG, R.S.K. LO, C.L.W. CHAN
1 Togetherness
2Miss Candy FONG Hio-cheng, Research 
Coordinator, Centre on Behavioral Health, the 
University of Hong Kong
Many patients approaching the end of life are 
confronted with spiritual concerns related to a sense 
of personal integrity, meaning of life, and a fulfilled 
past. This presentation uses a case story to present 
how a qualitative study can be integrated with 
community intervention in helping patients searching 
for spiritual peace in their end of life. 
Three semi-structured interviews were conducted 
with the case who was a male older adult receiving 
palliative care in Sha Tin Hospital, Hong Kong. 
Findings reveal that a sense of self integrity through 
fulfilling familial responsibilities, seeking forgiveness 
and reconciliation of significant relationships are 
important themes contributing to the patient’s 
spirituality. As a follow up of the qualitative study, a 
charity organization in Hong Kong, Togetherness, 
provided a life review and meaning-making 
intervention in helping the patient to search for 
spiritual peace. Volunteers of the organization visited 
the patient and provided intervention with the 
following focuses: (1) Life Integration: Revisit and 
reinterpret regretful life experiences focusing on what 
is learnt from these experiences and the meaning of 
life; (2) Relationship reconciliation: Visit mother’s 
tomb, express love, gratitude and seek forgiveness 
from family, and family photo taking; (3) Living in 
the moment: Participate in social gatherings such as 
birthday party and festival celebrations and develop 
photography as new hobby. The intervention is 
successful in regaining a sense of personal integrity, 
connectedness, and spiritual peace.
The Effectiveness of the Spiritual Care Group 
for Promoting Spiritual Health to the Frail 
Elders in Nursing Home
Daniel LAW H.Y.*, K.K. LO, W.T. LEE, K.W. LI, M.Y. 
CHAN, K.P. WAN
Objective
To examine the effectiveness of spiritual care group in 
improving the spiritual quality of life of frail elders.
Method
Under a hospice care program, twenty residents with 
Chinese version of the Mini-Mental State Examination 
(CMMSE)(Chiu et al. 1994) scored over 22 were 
recruited in Hong Kong Sheng Kung Hui Nursing 
Home and were randomized into experimental and 
control group, each with ten subjects. The 
experimental group received eight sessions of 
spiritual care group while the control group received 
eight sessions of general social activity in eight weeks.  
The Spirituality Part of Body-Mind-Spirit Well-Being 
Inventory (BMSWBI) (Ng et al. 2005) was  
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dministered to assess their spiritual quality of life. 
Measurements were taken before and after the 
intervention.
The spiritual care group has eight sessions. 
Through meditation, breathing, body scanning, 
one-minute health techniques (Chan 2006), mindful 
eating and life review, group members’ serenity, 
gratefulness, self assurance and ability to let-go are 
developed. As a result, the members’ spiritual 
quality of life is improved.
Results
In the spiritual care group, group members were 
facilitated to learn and to practice forgiveness and 
gratefulness, and also to demonstrate a moderate 
state of mind and inner harmony.
Mann-Whitney Test was used to analyze the date 
collected through the Body-Mind-Spirit Well-Being 
Inventory(BMSWBI), it is shown that the 
experimental group (score change = +22.2) has a 
significant improvement of spiritual quality of life 
when compared to the control group(score change 
= -5.9) (z=-3.79, p<0.05). 
Conclusion
This study provides preliminary evidence that 
spiritual care group can improve the spiritual 
quality of life of dependent elders. The experience 
of that spiritual care group sheds light on 
developing a new approach in improving spiritual 
quality of life in hospice care in Hong Kong. 
Meaning-focused intervention for advanced 
cancer patients
Theresa Lai T.K.*, E. MOK
*Nursing Officer, Department of Oncology 
(Palliative Care), Princess Margaret Hospital
Objective
The objective of this study was to explore the 
impact of a brief, individualized meaning-focused 
intervention for advanced cancer patients.
Method
This study employed a single blinded randomized 
controlled trial design with intervention and 
control groups, and measures taken at baseline, 
immediately after intervention, and one week after 
intervention. Quality-of-life concerns in the end of 
life questionnaire (QOLC-E) will be used as the 
measurement. There are 2 sessions for the 
intervention. Baseline measurement will be 
performed before the intervention. The first session 
involves a semi-structured interview that facilitates 
the search for meaning. The second session is to 
review, verify, and clarify the findings from the first 
session with the patients. The second and third 
measurement will be held one day and two weeks 
after the intervention for outcome measurements. 
Results
The score of existential distress domain, quality of 
life and overall scale of QOLC-E of 
meaning-focused intervention group were 
significantly higher than the control group. The 
results showed significantly improve quality of life 
in existential distress domain of meaning-focused 
intervention group. In addition the negative 
emotion domain, support domain, value in life 
domain, existential distress domain, quality of life 
and over scale of QOLC-E of intervention group 
improved after intervention. Apart from the 
improvement in the intervention group, support 
domains of both groups in the third measurement 
were improved after the study.
Conclusion 
The findings of this study showed the brief 
meaning-focused intervention helps improve 
existential wellbeing and quality of life of advanced 
cancer patients.
Challenges of families living with frail older 
persons at the end of life
Ada Lau T.Y.*, S.M.C. PANG, D.C.N. YAU, Y.M. 
WU, K.S. CHAN
*Advanced Practice Nurse, School of Nursing, The 
Hong Kong Polytechnic University
Objective
Sustaining home care for frail older persons at their 
final days is an ideal situation. This paper focuses 
on the narratives of families as they reflect on the 
care challenges in sustaining home care for frail 
older persons at the end of life and expound how 
the family caregivers address the issues along the 
illness trajectory. 
Method
An interpretive phenomenological approach was 
used. Individual interviews of fourteen family 
caregivers who planned to continue the care of frail 
older family members at home after discharge from 
hospital were conducted. They were further 
followed up at one month and three months after 
the first interview for any change of care 
preferences. 
Results
Nine out of the fourteen frail older persons died in 
hospital during six months of the study, seven 
required institutional care and four died without 
utilization of old age home. Four themes emerged: 
(1) Home as preferred caregiving place, 
(2) Factors influencing home care sustainability, 
(3) Critical decision points for changing places & 
(4) Challenges in facing death and dying. 
These four themes interplayed patterns of 
caregiving trajectory of frail older persons at the 
end of life. 
Conclusion
The findings revealed important insights of care 
resources alignment and moral challenges faced by 
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the family caregivers in sustaining living in place 
for frail older persons at the end of life. Their voices 
are explicit. They need to be listened and comforted 
in facing death and dying of the senior family 
members.
End-of-life care issues: attitudes of older 
people living in residential care homes
Ms. Noble LAW P.K.*, C.W.H. CHAN
*Professional Consultant, The Nethersole School of 
Nursing, The Chinese University of Hong Kong
Volunteer Work for End-of-life Care Services
Objective
To examine the attitudes toward end-of-life (EOL) 
care issues and preference of place of death in older 
people living in residential care homes for the 
elderly (RCHEs). 
Method
Cross-sectional quantitative study method was 
used. The attitudes toward EOL issues 
questionnaire from a UK study was employed and 
was translated into Hong Kong Chinese version. A 
structured questionnaire was used to collect the 
data by face-to-face interview. RCHE older 
residents who were cognitively competent with 
AMT >6 were recruited. 
Results
A total of 150 older people [113 females and 37 
males] with an average age of (mean ± SD) 83.3 ± 7 
(range 65 to 96) were included. Results showed that 
if they were severely ill with no hope of recovery, 
86.6% would prefer the doctors to make all the 
decisions about their care, 65.3% would not want to 
be kept alive at all costs and 70% preferred to die at 
the present of family members. In addition, 99.3% 
of residents perceived RCHEs as their own home 
and 76% actually wished to die in RHCEs. Most 
residents were willing to discuss about EOL care 
issues during the study.
Conclusion
The results of this study show that many older 
people wish to spend the last journey of their lives 
in RCHEs because they perceive RCHEs as their 
own home. It advocates the need of providing EOL 
care services in RCHEs in Hong Kong. Knowing the 
attitudes of older people in RCHEs toward EOL 




“Spirituality can be defined as the essence of our 
humanity” (Frankl, 1984). Spirituality therefore is of 
primary importance in the dying. 
The workshop starts with a brief explanation of what 
terminal patients’ spiritual needs are, how these needs 
are manifested, as well as direction and goal of 
spiritual care. Then participants take part in case 
discussion and exercises to understand how dying 
patients with spiritual distress are supported and their 
issues addressed. 
Last but not least, participants are taken through 
practices to prepare themselves to be in tune 
with how their own spirituality affects their 
work with the dying.
 Workshop - Spiritual Care in the End of Life
Dr. Kitty Wu presenting souvenir to Dr. Rhoda Yuen
Dr. Rhoda Yuen facilitating participants to reflect 
on the spiritual needs of patients  
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Report on 9th Asia Pacific Hospice Conference
The Malaysian cultural dance performance  
The buzzling conference banquet  
The Hong Kong delegates gathered together   
The conference banquet was held on the 
evening of the third day in a vibrant atmosphere. The 
entertainment, the mini showcase of Malaysian cultural 
dances in Asian fusion music, was enjoyable and 
fascinating. The evening was brought to a climax when 
all participants danced with the music after the dinner. 
With the soaring mood of the delegates, they reached 
their hands up to get the white and purple balloons as 
souvenirs – a perfect way to end the evening. 
Last but not least, Penang is a gourmet's paradise, especially 
when it comes to hawker’s food. Of course, the Hong Kong delegates 
would not miss this golden opportunity to enjoy the mouth watering 
Malaysian cuisine in hawker food stalls. Gifted with the tropical climate, 
Penang is famous for producing fruits like durian, rambuta and duku 
langsat. Who would care about the few pounds of body weight that we 
all put on? Yummy! 
 
From all accounts, the conference was a great success. The 10th 
and the 11th Asia Pacific Hospice Conference will be hosted by Bangkok in 
2013 and by Taiwan in 2015 respectively. See you then. A typical hawker food stall in the street of Malaysia
A palliative experience with Amyotrophic Lateral Sclerosis
Case history
Mr. Ho is a 58-year-old male with past history 
of diabetes mellitus and hypertension. He first 
presented in late 2009 with an insidious onset of 
right leg weakness. Signs of right lower limb 
wasting, fasciculation and brisk reflexes were 
seen without any sensation involvement. The 
clinical suspicion of ALS was supported by nerve 
conduction test / electromyographic studies 
which showed denervative changes in several 
muscle groups.
Over the next year, Mr. Ho was followed up at 
intervals by the Neurology team. His limb power 
further worsened despite a trial of riluzole. By the 
end of 2010, his bilateral lower limb power was 
reduced to grade 0/5 and he was wheelchair 
bound. 
In March 2011, Mr. Ho was admitted via the 
emergency department for acute respiratory 
failure due to pneumonia. By that time, he was 
suffering from dysphonia with prominent wasting 
of muscles over the chest and four limbs. 
Non-invasive ventilation (NIV) was started as 
agreed by Mr. Ho after discussion. However, it 
was soon noted that he remained NIV-dependent 
despite the clinical response of his pneumonia to 
antibiotics therapy. The issue of enteral feeding 
was also brought up during this admission. 
Expert opinions from the gastrointestinal 
endoscopist, anaesthetist, and intensive-care 
colleagues concluded that Mr. Ho was a high-risk 
candidate for percutaneous gastrostomy tube 
insertion. Understanding the risks involved, Mr. 
Ho decided not to accept the procedure. 
Consultation to the Palliative team was made 
before Mr. Ho was discharged home with the NIV 
machine. Home visits were paid to Mr Ho’s family. 
Within the month from his discharge, his 
weakness progressed further to involve his upper 
limbs. He was still able to feed on gastric diet, 
and was tolerating a whole-day use of NIV. He 
received his care mainly from this wife with the 
help of a newly employed maid. The overall 
coping at home was satisfactory although his wife 
did express some physical fatigue from the 
constant turning and lifting of Mr. Ho’s dependent 
body. 
The issues of future care plan were raised, 
including the anticipated deterioration in 
dysphagia and the failure of NIV in support of his 
respiratory function. Mr. Ho quite readily recalled 
his previous decision not to take the risk for 
endoscopy, but would accept the use of 
nasogastric tube for feeding. Regarding the 
application of long-term mechanical ventilation, 
however, Mr. Ho appeared evasive and denied 
having heard of the option before. It was during 
one of the later visits that Mr. Ho revealed that 
this issue of mechanical ventilation had in fact 
been brought up before during his hospitalization, 
and it was decided at that time that he would not 
want a tracheostomy performed. Yet upon 
revisiting the issue, he remained hesitant.
The palliative team will continue the 
supportive care for Mr. Ho. It is recognized that 
ongoing exploration of his wish and preferences 
will be necessary, for these may subject to 
change over time and the course of his illness. 
Psychospiritual support to both Mr. Ho and his 
carers is also essential, with particular attention 
to be paid on possible development of 
depression and carer fatigue.
A Palliative Experience with Amyotrophic Lateral Sclerosis
Dr. Mok, Ka Wai Alice, Palliative Care Unit, Shatin Hospital.
Correspondence: mkw474@ha.org.hk
ABSTRACT
      Amyotrophic lateral sclerosis (ALS) is a progressive motor neurodegenerative disease. The mainstay of 
treatment is supportive. An early referral to palliative care is advocated. The anticipated loss of functional 
capacities in the disease makes advance care planning of particular importance. Options of assistive 
devices need to be considered. Through the experience of a case, it can be seen that discussions on 
life-sustaining interventions can be complicated, and the preferences made are subject to change over time. 
There is sufficient evidence that the quality of life in ALS can be maintained even as the physical function 
declines.
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Timing of referral
The anticipated declining trajectory makes the 
diagnosis of ALS daunting to most. The treatment 
for ALS approved at best delayed the progression 
of disease by a few months. Practical decisions 
and arrangements on supporting the anticipated 
losses of body functions have to be made along 
the course of illness. Our experience with Mr. Ho 
shows that time is required to establish rapport 
with the patient and the family in order to facilitate 
these discussions. An early referral to the 
palliative team, therefore, will be desirable in the 
decision-making process.
The European Federation of Neurological 
Sciences taskforce recommended that a 
palliative care approach to be adopted early in 
the diagnosis of amyotrophic lateral sclerosis 
(ALS), and a referral to hospice or home care 
teams to be initiated well in advance of the 
terminal phase of the disease.1 However, data 
showed that less than half of the palliative care 
units in UK provided ALS care, and only <10% of 
the diagnosed cases had palliative care 
involvement from the time of diagnosis.2 
In the US access to hospice care is subject to 
more stringent criteria as set by Medicare. The 
US-based ALS Peer Workgroup3 also suggested 
the following triggers for hospice referral:
1.  FVC 60% predicted (or rapid decline >2% over 
2-3 months); or
2.   Clinical signs or symptoms of respiratory 
insufficiency; or
3.   Respiratory weakness requiring non-invasive 
ventilation; or
4.   Nutritional decline requiring enteral feeding; or 
5.   Severe pain or psychosocial distress requiring 
intensive palliative care interventions (including 
opioid medication); or
6.   Rapidly progressive paralysis (over 2-3 
months) in two body regions
Advance care planning in ALS
 The predictable decline of mobility, breathing, 
eating, talking and even thinking – all being the 
most basic functions one is born with, makes 
advance care planning (ACP) one of the most 
important aspects in the palliative care for ALS. 
The challenges to the palliative team will be not to 
overwhelm the patients with all the possibilities of 
the life-threatening conditions, and yet not to 
delay the discussions till when it is already too 
late.   In this respect, an understanding of the 
natural history of ALS will be valuable in the 
timing of broaching these discussions. 
Brooks et al4 provided some insights on the 
trajectories of ALS by studying the different 
symptoms and functions in 155 bulbar-onset and 
547 spinal-onset ALS patients. They found that 
the segmental spread of symptoms was faster 
than rostral or caudal spread, and the bulbar 
symptoms occurred faster in patients with arm 
rather than leg onset of disease. Swallowing 
symptoms, on the other hand, occurred earlier 
following bulbar onset rather than arm/leg onset. 
Various rates of decline were observed in terms 
of muscle strength loss, with proximal muscles 
involved at a later stage than distal groups, and 
flexor muscles being more affected than extensor 
muscles. Respiratory failure is the main cause of 
death in ALS. In this study, a follow-up of the 
forced vital capacity (FVC) of these patients 
showed that the FVC in bulbar-onset ALS 
decreased faster than limb-onset patients. 
Ventilatory support
Invasive mechanical ventilation 
The application of ventilators is a common 
consideration in ALS. Some patients may 
experience an acute respiratory failure against 
the background of a gradual decline. Others may 
have previously expressed their wish to receive 
ventilator support in the event of late-stage 
pulmonary failure. For some, respiratory failure 
may be the presenting condition of their disease.   
While mechanical ventilation may provide the 
support required to prolong survival, the 
outcomes of ventilator use will also be worth 
considering before the start of the device.
Bradley et al5 reviewed 24 ALS patients who 
were intubated within hours of presentation. 
Among them, 17 had their respiratory failure as 
the presenting symptom. Only 1 patient was able 
to be weaned from ventilator support in the end. 
Sixteen patients required long-term respiratory 
support with 13 of them being put on invasive 
positive pressure ventilation via a tracheostomy. 
The remaining patients died during the 
admissions. Chadwick et al6 reported similar 
findings in their review of 30 patients. One of 
them died and 13 failed to wean off the ventilator 
support. Among the 14 patients who were 
weaned to non-invasive ventilation, 13 required 
nocturnal use only. 
Although the mean survival of less than a year 
was reported in the ventilated group5-6, a 
prolonged survival of up to years can be seen7.  
No predictor can suggest for certain the expected 
survival before the start of ventilation. In the 
report by Hayashi7, however, over half of the 
patients who had been using ventilation for over
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five years were reduced to either a minimally 
communicable state or even a totally locked-in 
state. The author recommended that discussions 
and planning to maintain effective communication 
should take place when planned for mechanical 
ventilation.
Non-invasive ventilation (NIV)
Domiciliary NIV is gaining popularity in recent 
decades as a means of respiratory support. Its 
application in ALS not only improves survival8-10, 
but also postpones the start of long term invasive 
ventilation. Guidelines from the American 
Academy of Neurology11 suggested the use of 
NIV for symptomatic hypoventilation. Studies 
have also supported that NIV slows the decline of 
pulmonary functions12-13 in tolerant patients, and 
helps in relieving orthopnea13. Improved quality of 
life was observed, and this improvement 
persisted despite disease progression8,13. The 
severity of bulbar weakness is a predictor of 
tolerance to NIV. Tolerance to NIV, as well as the 
rate of pulmonary function decline, were found to 
be the only independent predictors of survival in 
ALS12. It is reassuring to see in the study by 
Mustfa et al8 that NIV did not adversely affect the 
burden or stress experienced by caregivers.
Feeding issues in ALS
Bulbar weakness often manifests as 
dysarthria and dysphagia in ALS. Dysphagic 
patients are at risk for inadequate nutrition, 
resulting in a worsened state of muscle wasting, 
fatigue and weakness. As dysphagia progresses, 
enteral feeding should be considered. 
Percutaneous endoscopic gastrostomy (PEG) is 
widely used as an alternative or supplemental 
route for oral feeding. 
The American Academy of Neurology practice 
parameter guidelines11 suggested that the initial 
management of dysphagia includes the 
modification of food and fluid consistency, and 
patients should be followed by a speech 
therapist. Placement of PEG should be 
considered in the presence of symptomatic 
dysphagia with accelerated weight loss, 
dehydration, or premature ending of meals due to 
swallowing problems or choking. The timing for 
PEG insertion should be considered in the 
context of pulmonary status.  Ideally PEG should 
be inserted before the forced vital capacity (FVC) 
falls below 50% because the risk of respiratory 
complications from the procedure increases with 
the decline in pulmonary function. 
Some patients may unfortunately present with 
a compromised respiratory status at the time of 
diagnosis, while others may have undergone a 
rapid deterioration in pulmonary function before 
the decision for PEG placement could be made.  
The use of NIV as an adjunct during PEG 
insertion had been evaluated for its potential 
benefit in preventing respiratory complications.  
Boitano14 described the successful insertion of 
PEG with NIV support in all five patients studied. 
No respiratory complications occurred and these 
patients were discharged the day after the 
procedure. Gregory15 reviewed 33 patients with 
FVC <50% predicted who attempted PEG 
placement using NIV. PEGs were successfully 
placed in all patients, with an oxygenation 
maintained >88% during the procedure. No 
significant in-hospital mortality or morbidity was 
noted. These findings suggested that with the use 
of NIV, the quality of life and survival benefits of 
PEG placement may be extended to the group of 
ALS patients whose respiratory function is 
already compromised from the disease to a 
moderate degree.
Percutaneous radiological gastrostomy 
(PRG), which makes use of fluoroscopic 
guidance for tube insertion in an air-insufflated 
stomach, has also been studied for its application 
in ALS patients with FVC<50%. Chio et al16 
compared the use of PRG versus PEG and found 
that the decrease in FVC one month after the 
procedure was significantly less in the PRG 
group, and the median survival of the PRG group 
was significantly longer. The authors concluded 
that PRG was a safe and effective alternative to 
PEG in patients with moderate or severe 
respiratory failure.
Patients’ choices in ALS 
Despite all the advances over the years, ALS 
remains a disease with poor prognosis without 
yet a curative treatment. While it is difficult to 
disclose the diagnosis to patients, it is equally 
challenging to discuss with them the anticipated 
course of the disease, and the options of 
life-sustaining interventions. The timing of such 
discussions has also been put under question. To 
make informed choices, patients would require 
sufficient information and adequate support from 
the medical team. It is expected that such 
decisions may change over time with patients’ 
evolving physical and psychological states, as 
well as an improved understanding with ongoing 
education and information seeking. 
Albert et al17 undertook a prospective study 
that assessed patients’ preferences for the use of 
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tracheostomy and PEG placement, and how 
these preferences early in the disease were 
related to later treatment choices. Their results 
showed that only a small proportion of the 
patients expressed their preferences for the 
interventions early, but these early preferences 
predicted their later choices. It was noted that 
those who found the interventions acceptable 
were more likely to be recently diagnosed, 
expressed greater attachment to life, and showed 
greater declines in pulmonary function over 
follow-up.
Hope and the future 
Riluzole, an inhibitor of presynaptic glutamate 
release, is currently the only drug with shown 
efficacy in slowing the progression of ALS. With 
improving understanding of the pathogenesis 
underlying ALS, novel targets for intervention 
have been emerging18, with some promising 
studies now entering into the phase 3 trials. 
Hopefully new therapeutic agents with better 
efficacy will be available in the near future.
It is reassuring that studies which focused on 
the quality of life (QOL) of ALS patients similarly 
showed that their QOL can be maintained. 
Specifically, Simmons et al19 found that QOL in 
these patients did not correlate with physical 
function, a finding which was further supported by 
later studies.20-22 Psychological, spiritual and 
social factors all appeared to play a role in 
determining the QOL in ALS patients.19-22 
These findings underline the importance of 
palliative care in ALS, suggesting that the 
attentions of care to be paid not only to the 
physical side of the patients, but also to the 
psychospiritual and social aspects of them as 
well as their caregivers. It can be anticipated that 
an integrative approach between the neurology 
and palliative teams shall remain desirable until 
the day when advances in technology have 
brought a complete cure to the disease. 
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A palliative experience with Amyotrophic Lateral Sclerosis
Who or what defines a “caregiver”?
The term “caregiver” is used synonymously 
with the term “carer”. The Oxford English 
dictionaries defines “carer” as “a family member 
or paid helper who regularly looks after a child, or 
a sick, elderly or disabled person”1. The National 
Institute of Clinical Excellence (NICE), in their 
2004 report ‘Guidance on cancer services 
improving supportive and palliative care for 
adults with cancer’, define “caregivers” as “lay 
people in a close supportive role who share in the 
illness experience of the patient and who 
undertake vital care work and emotion 
management”2. However, the definitions of 
caregiver used in research can be quite diverse. 
Some research definitions define “caregiver” as 
“someone most or primarily involved in the 
patient’s care, or providing most or the majority of 
the care or assistance”3. Other definitions used in 
research are based on a minimum task or time 
commitment e.g. at least 8 hours per day, more 
than 20 hours per week3.
Caregivers may include people not related by 
blood or legal ties. They may be geographically 
dispersed, and not necessarily confined to the 
same household as the patient. Caregivers may 
include blood-related family, extended family, 
friends or even neighbours.
Caregiving tasks
Caregiving is a dynamic process4. The burden 
of caregiving changes with time. There is a 
marked variation in the range and extent of care 
provided; the care provided often based on daily 
judgments by the caregiver of perceived patient 
need and capabilities5,6.
Caregiving tasks include direct 
(extrapersonal) care and interpersonal care4. 
Direct care includes management of symptoms 
and medications, personal care, domestic 
chores, ambulatory & emotional support provided 
directly to the patient. Interpersonal care involves 
partaking in interaction with health care 
professionals, other relatives and meeting the 
needs of other family members.
Historically, in caregiving, visible care has 
been more valued because it tends to be more 
public, technical and easier to compensate 
financially than invisible care work. However, 
caregivers will tell tales of how the care they 
provided extends beyond the physical and 
visible. 
Visible care includes observable behaviours, 
including forementioned extrapersonal and 
interpersonal care. Visible care is, without doubt, 
time consuming and tiring. However, invisible 
care requires significant effort and engagement 
from the carer, and is carried out as a constant 
surveillance – monitoring and assessment of 
signs/symptoms, and patient’s energy levels6.  In 
contrast to visible care, invisible care is not 
necessarily associated with observable behavior 
or with the patient’s knowledge and is often 
reported as constant, even when the patient is 
sleeping6. 
Importance of caregivers in Palliative care
Over the last few decades, developed nations 
have witnessed significant demographic and 
social changes3. Demographically, we are seeing 
an aging population and declining fertility rates. 
The stress and burden of caregiving
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ABSTRACT
      Health and social services rely heavily on family and friends for caregiving at the end-of-life. Caregiving 
is a challenging experience, with negative consequences for the caregiver. Nonetheless, the experience 
can be a transformative and meaningful one. With an aging population and declining fertility rates, the 
burdens of caregiving are on the rise. As health care professionals, we need systems in place to support 
caregivers, because as a community, we are going to rely on them again and again7. 
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With an aging population, we are serving more 
people with chronic progressive illnesses within our 
health care systems. Socially, we have an 
increased female labor force and families are 
geographically dispersed as family units and 
households become smaller. Elderly, dependant 
parents are seen geographically dispersed from 
their only support, their children. 
These demographic and social changes 
come-about at around the same time, when the 
context in which we provide palliative care is 
in-itself, undergoing significant changes. Some of 
the changes we are seeing in the provision of 
palliative care is an increasing emphasis on 
home-death and a shift in the focus of care for 
patients from the hospital to the home4.
Achievement of death or care at home depends on 
the availability and willingness of caregivers to 
provide care. Having a caregiver has been shown 
to be the single most important predictor of home 
death7.
Caregivers form the very backbone of health 
and social care delivery3. Both health and social 
services rely heavily on family and friends for 
caregiving at the end of life. Without such help, our 
health and social systems would fail7.
Although home death is more an exception than 
a commonality in our local setting, palliative care 
still places an emphasis on enabling the patient to 
live at home for as long as possible8.
 Caregivers provide a substantial yet hidden 
contribution to our economy. In the US, caregiver 
contributions to the economy were estimated to be 
around US$ 196 billion annually7. In Australia, the 
contribution of caregivers to the cost of health & 
social care was estimated annually to be 
approximately 50% of the total national 
government’s expenditure on health7. In the UK, it 
has been estimated that the overall value of their 
care is greater than the cost of the National Health 
Service (NHS). 
Caregivers significantly influence both health 
outcomes and costs in terms of readmission rate 
and use of inpatient facilities9. It is predicted that 
with recent social and demographic changes, fewer 
caregivers will be available to provide care and with 
more people dying with complex care needs, the 
burdens of caregiving are likely to increase10.
Mixed impact of caregiving
Caregiving has been shown to have a negative 
impact in various domains of life for 
caregivers3,4,8,9,11.
HKSPM Newsletter 2011 Oct Issue 2 P30
Domain   Examples of impact on caregivers
Physical   Strain, fatigue, sleep deprivation
Psychological/Emotional Stress, anxiety, depression, helplessness, loss of control
Social    Fewer social contacts, fewer opportunities to socialize
Financial & occupational Occupational disruption, financial strain
Disrupts daily schedule Less time available for oneself, 
    presence of fatigue leaves the carer less motivated
The stress and burden of caregiving
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1. Information
2. Regular access to specialist practitioners
3. Advice and training on how to fulfill their caring role
4. Psychological support
5. Practical help with personal, nursing and medical care of the patient
6. Domestic help
7. Financial aid
8. Out of hours, or night support
9. Respite
10. Integrated care service
Despite the possible negative impact on 
caregiving, some caregivers were able to 
appraise the experience as rewarding and/or 
meaningful3. Caregivers who found the 
experience meaningful perceived themselves to 
be healthier than those who saw little/no purpose 
in the caregiving role5.
What is it that “transforms” the stress and 
burdens of caregiving into a positive experience? 
Research has shown that caregivers own 
spirituality helped them find meaning and 
purpose in their stressful situations, which helped 
them transcend the demands of caregiving3. 
Religious commitment, or 
viewing themselves as 
having a relationship with 
God, self or the environment 
also helped transform the 
caregiving experience into a 
positive one5.
Whether the caregiving 
experience has an overall 
positive or negative impact 
on the caregiver depends on 
the inter-relatedness of the 
caregiver-patient dyad4. For 
the caregiver, it depends 
upon the degree of 
self-efficacy the caregiver
feels over a particular experience, the caregivers’ 
perceived rather than actual capabilities, 
increased caregiver skill and competence, 
caregivers’ optimism and positive appraisal4. The 
overall impact on the caregiver also depends 
upon the patients’ symptoms, distress, immobility 
and dependency in activities of daily living9. 
Problems identified by caregivers
 Research has    shown that caregivers have 
had to deal   with various problems within the 
health care service, which they hope could have 
been addressed to help make their caregiving 
experience a more fulfilling one. Some of the 
problems include uncoordinated and patchy 
provision of formal care, lack of a multi- 
disciplinary team, lack of communication 
between informal and formal caregivers and lack 
of communication between formal caregivers 
making up the team11. Where there were gaps in 
the needs & the service provision for cancer 
patients & their caregivers, the systems in place 
for non-cancer illnesses were even more 
deficient.
Caregiver needs
Research on caregivers has shown that they 
have their own needs, which if addressed, can 
help make their caregiving experience less 
stressful and burdensome. 
Some of the needs identified by caregivers 
include3,8,9,10,11
What can we do to improve caregivers’ 
caregiving experience?
Caregiving is an experience, which puts 
significant physical and emotional toll on 
caregivers. As health care professionals, we 
must assess caregivers’ physical and mental 
wellbeing as they commence their roles; and this 
needs to be assessed on a continuing basis as 
well. We need to constantly reassess caregivers’ 
willingness to continue in the caregiving role7. We 
need to distinguish between caregivers who are 
absolutely unable to take on the caregiving role 
versus those unwilling to do so. 
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We should not falsely assume that caregivers 
will be there when we need them. We need 
systems in place to support caregivers, because 
as a community, we are going to rely on them 
again and again7. 
To support caregivers, we need to 
acknowledge the caregivers’ role and affirm the 
importance and inherent difficulties in fulfilling that 
role. We need to understand the needs of 
caregivers and the inter-relatedness of the 
patient-caregiver dyad7. 
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Case history 
Ms C, 78 year old woman, was transferred to 
us for palliative care of colon cancer. Ms C had 
history of end stage renal failure due to unknown 
cause, hypertension and hyperlipidaemia. She 
suffered from ischemic stroke resulted in left 
hemiparesis.
She was on continuous peritoneal dialysis for 
ten years already. Initially she performed the fluid 
exchange herself, but after she suffered from 
stroke, she was transferred to old age home. 
Nursing staff in the old age home performed fluid 
exchanges for her.
Two months ago she presented with upper 
abdominal pain and new onset anaemia. 
Subsequent colonoscopy showed adeno- 
carcinoma of proximal colon. CT scan showed 
liver metastasis and peritoneal lymph node 
metastasis. After discussion with family and 
patient, she did not want any active oncological or 
surgical treatment. 
Her main symptom was right upper quadrant 
distending dull aching pain related to distension of 
the liver capsule from hepatomegaly because of 
liver metastasis. She also had progressive 
anorexia and weakness, malaise, and nausea with 
significant cachexia. In the acute ward, the use of 
tramadol did not achieve optimal pain relief. Our 
palliative team was consulted and she was 
transferred to us for further inpatient care with pain 
and symptom control. She was still on dialysis. 
Issue of termination of dialysis was discussed, 
patient and family came to consensus that as the 
burden of fluid exchange was limited and tolerable 
to her, and she had been on dialysis for long time 
without significant complications, they both 
preferred to continue dialysis. During her stay in 
our ward, our nursing staff performed the fluid 
exchange for her and it was uneventful. 
Palliative care of a patient with end stage renal failure and cancer 
Dr Bryan Li
Palliative Medical Unit, Grantham Hospital
ABSTRACT
      We presented a patient with end stage renal failure on peritoneal dialysis and colon cancer. Pain control 
in renal failure was discussed. Palliative care needs of renal patients were also discussed. 
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Pain control was improved after stepping up 
the analgesic to methadone. Psychosocial 
support was offered by nursing staff. Grief and 
bereavement needs were well attended by 
medical staff and bereavement counselor. Family 
grief was supported. Patient finally succumbed 
after two weeks of stay in our palliative care ward. 
Discussion 
Pain is a common symptom in the cancer 
patient and also in patients with end stage renal 
failure.  Pain control is especially complicated 
among patients with renal failure because of the 
accumulation of toxic metabolites and hence 
increased risk of side effects. In a survey about 
pain in patients with renal failure, musculoskeletal 
pain was most common (62%), followed by 
gastrointestinal (13%), and genitourinary (10%)1. 
Pain control in patients with renal failure 
needs special attention to the pharmacokinetics 
of the drugs used. For example, morphine is 
metabolized in the liver to morphine-3 
-glucurinade (M3G) (55%) and morphine-6- 
glucurinade (M6G) (10%), nor-morphine (4%) and 
codeine, all of which are renally excreted. They 
may accumulate in patients with renal failure. 
M6G can cross the blood brain barrier, causing 
central nervous system (CNS) side effects like 
somnolence and dizziness.  Morphine has low 
protein binding and moderate water solubility, so 
it is likely to be removed during dialysis. M6G is 
removed by dialysis but its slow diffusion out of 
the CNS delays the removal during dialysis. 
A recently published review2 showed that the 
half-life of the parent opioid compounds and of 
their metabolites is increased in the presence of 
renal dysfunction, for which careful monitoring of 
the patient, dose reduction and a longer time 
interval between doses are recommended. 
Among opioids, morphine and codeine should be 
used with high caution and possibly avoided in 
renal failure/dialysis patients; tramadol, hydro- 
morphone and oxycodone can be used with 
caution and close patient monitoring, whereas 
transdermal buprenorphine, methadone and 
fentanyl appear to be safe to use in patients with 
renal failure.
Patients with renal failure and dialysis have 
high palliative care needs. 
In a local survey of 179 patients3, 45 patients 
(25.1%) in the palliative care group and 134 
patients (74.9%) in the dialysis group, fatigue, 
cold aversion, pruritus, lower torso weakness and 
difficulty in sleeping were the five most prevalent 
symptoms in both groups, and were also among 
the most intense symptoms. Quality of life was 
significantly impaired in both groups. Scores of all 
quality of life domains correlated negatively with 
the number of symptoms (P < 0.001). Patients 
with end stage renal failure under palliative care 
and dialysis had overlapping symptom 
prevalence and intensity, significant symptom 
burden and impaired quality of life. 
Actually palliative care needs for cancer 
patients and patients with non-cancer life limiting 
illnesses are both significant. This is not just true 
for renal failure patients, it is also true for other life 
limiting illnesses. Recent study comparing the 
illness experience of patients with cancer, heart 
failure and chronic obstructive pulmonary disease 
showed that their illness experience depend more 
on the disease severity, demographic features 
and emotional and social well-beings4. For 
example, quality of life, depression and anxiety 
are strongly associated with demographic data 
like gender, ethnicity and education level rather 
than disease category. 
Advance care planning is important. Advance 
care planning is the process of discussion 
between an individual and their health care 
professionals about future needs5. Helping a 
patient establish their priorities in end of life care 
enables them to plan their future and prepare for 
death, allowing them to maintain control over their 
wants and wishes6. This is also important in 
patients with end stage renal failure. We had 
discussed the care plan with patient and their 
family in this case. They chose to continue with 
dialysis after considering the benefit and burden. 
We respected their wishes. 
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Introduction
Malignant pleural effusion is a common 
problem encountered in palliative care. The 
presence of malignant pleural effusion signifies 
disseminated or advanced disease and limited 
life expectancy. Median survival ranges from 3 to 
12 months. 1 Majority of the patients with 
malignant pleural effusion are symptomatic. 
Dyspnoea is the most common presenting 
symptom followed by chest pain and 
constitutional symptoms including weight loss, 
malaise and anorexia. Recurrent malignant 
pleural effusion significantly impairs function and 
worses quality of life of the patients.
The primary therapeutic goal of management 
is effective palliation of dyspnoea while 
maintaining quality of life and minimizing 
hospitalization has equivalent importance. 
Treatment options are determined by several 
factors: symptoms, performance status and life 
expectancy of the patient, the primary tumor type 
and its response to systemic therapy. Options for 
management include observation, therapeutic 
pleural aspiration, intercostal tube drainage and 
instillation of sclerosant, thoracoscopy and 




Observation is recommended if the patient is 
asymptomatic but majority of the patients will 
become symptomatic and require intervention in 
due course.
Therapeutic pleural aspiration
For patients who are frail or terminally ill with 
limited life expectancy (<1 month) and poor 
performance status, repeated therapeutic pleural 
aspiration can provide transient symptomatic 
relief. It should take place under ultrasound 
guidance and the amount of fluid drained should 
be limited to 1.5L on a single occasion.1 However, 
pleural aspiration alone is associated with high 
recurrence rate. 
Intercostal drainage and intrapleural 
instillation of sclerosant
Small-bore (10-14 F) chest tube drainage 
followed by pleurodesis is preferable to recurrent 
aspiration unless in significant trapped lung. 
Studies using small-bore catheters with 
commonly used sclerosants have similar success 
rates to large-bore catheters while less 
discomfort is caused. 2
Large pleural effusion should be drained in a 
controlled manner to prevent re-expansion 
pulmonary edema. On the first occasion, a 
maximum of 1.5L pleural fluid should be drained 
while any remaining fluid should be drained 1.5L 
at a time at 2 hour intervals. Drainage should be 
stopped if patient develops persistent cough, 
chest discomfort or vasovagal symptoms.1
Successful pleurodesis requires satisfactory 
apposition of parietal and visceral pleura but 
chemical pleurodesis may still be attempted 
when complete lung re-expansion or pleural 
apposition is not achieved, which is due to a 
dense peel of malignant tissue encasing the 
visceral pleura. (i.e. trapped lung). However, the 
amount of trapped lung compatible with 
successful pleurodesis is unknown. Indwelling 
pleural catheter may be a better option in the 
presence of complete lack of pleural apposition. 
Pleurodesis should not be delayed once the fluid 
drainage and lung re-expansion is 
radiographically confirmed while the amount of 
fluid drained per day before instillation of 
sclerosant is less relevant for successful 
pleurodesis. 3 
There are various sclerosing agents available 
and the choice will be determined by the efficacy, 
accessibility, safety, ease of administration and 
the cost but until now there is no consensus on 
the optimal agent. Some studies showed that talc 
is the most effective sclerosant available for 
pleurodesis.4 There are two ways of 
administration: talc slurry via an intercostal tube 
or talc poudrage using thoracoscopy. Success 
rates for talc slurry range from 81% to 100% and 
thoracosopic talc poudrage showed equivalent 
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effectiveness in one large randomized trial.5 
Common side effects observed with talc slurry 
include pleuritic chest pain and mild fever but a 
serious complication associated is adult 
respiratory distress syndrome (ARDS) or acute 
pneumonitis leading to acute respiratory failure. 
Graded talc (particle size >15 um) should be 
used to reduce the risk of severe hypoxaemia 
and ARDS. 6
Rotation is not required after instillation of 
sclerosants and the chest tube should be 
clamped for 1 hour after administration. Removal 
of chest tube is recommended within 24-48 hours 
of sclerosant administration in the absence of 
excessive fluid drainage (>250 ml/day). 1
Thoracoscopy
Thoracoscopy is now widely used in patients 
with good performance status for the diagnosis of 
suspected malignant pleural effusion, drainage 
and pleurodesis. The success rates range from 
77% to 100%. Under general anaesthesia, 
re-inflation of the lung can be visualized which 
will inform if the lung is indeed trapped and hence 
guide the decision of pleural catheter insertion or 
talc poudrage. Pleurodesis can also be 
successful in partially trapped lung since 
adhesions preventing re-inflation can be 
removed. 7 The most common major 
complications are empyema, acute respiratory 
failure and re-expansion pulmonary edema. 
Indwelling pleural catheter (IPC)
In patients not suitable for pleurodesis, in 
trapped lung or with recurrent effusion after 
pleurodesis, the use of a chronic indwelling 
tunneled pleural catheter for intermittent fluid 
drainage is an alternative method for relieving 
symptoms in malignant pleural effusion. IPC is a 
fenestrated, silicon catheter with a polyester cuff 
and a proprietary valve, placed under local 
anesthesia and connected to a vacuum bottle 
every few days for drainage of fluid.
Some studies have reported positive results 
with placement of IPC. A randomized controlled 
study showed that IPC is an effective treatment 
for recurrent malignant pleural effusion and 
requires a shorter hospitalization when compared 
with doxycycline pleurodesis via an intercostal 
tube. Besides, it can be managed on an 
outpatient basis. 8 The largest series reported on 
250 IPC inserted in 223 patients, 88.8% at least 
achieved partial symptom control. 9 Another 
series on 231 patients reported a removal rate of 
58% with only 3.8% reaccumulation and 2.2% 
infection.10
Therefore, IPCs are being used more 
frequently for patients in the field of palliative care 
where the length of hospitalization should be 
minimized. Though there is a significant cost 
associated with the devices, there may be cost 
reduction with a reduced length of hospitalization. 
Conclusion
The ideal treatment approach for patient with 
malignant pleural effusion should offer symptom 
relief, avoid hospitalization, have minimal side 
effects or complication and maintain quality of 
life. There is no clear consensus regarding 
optimal treatment but the management should be 
individualized. 
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LATTER LIFE FORUM
The Forum entitled “At Ease with Life and 
Death” was held on 30 July 2011 at the 
Auditorium of BGCA Building, Wanchai.  
Dr. Doris Tse (Palliative Medicine Specialist), 
Ms. Poon Siu Man (Journalist) and 
Mrs. Yvonne Siu (Media Veteran & SPHC 
Executive Committee Member) were the 
sharing speakers. More than 250 people 
attended with many positive feedbacks.  
The first speaker was Dr. Tse who is one of 
the pioneers in Palliative Medicine in Hong 
Kong. Inter-weaved her expertise in palliative 
care, she shared his father’s last life journey. 
In her seemingly simple and factual words of 
her blog, the audience was touched by the 
messages she conveyed in an inspiring way.  
It was felt like a struggle of or juxtaposing a 
healing doctor, a loving daughter and a 
caring caregiver supporting the whole family. 
Audience is thankful for Dr. Tse’s 
heart-warming sharing.
Ms. Poon is an experienced news reporter. 
She was one of the survivors at the Sichuan 
Earthquake. She was at Chengdu with her 
elder sister on 12 May 2008. She shared the 
incident from her perspective of trying to 
save her sister who suffered a 
life-threatening head trauma from the 
earthquake. Ms. Poon shared her journey of 
experiencing post-traumatic stress as well as 
her reflection and insights towards life. The 
incident has made her a more caring person 
and reporter.
Mrs. Yvonne Siu shares her personal insight 
as a retired professional, and advocates that 
we need to be proactive to learn about 
aging, and facing life’s inevitable.  She has 
pioneered a Life & Death Education program 
called 3G Quality Retirement Program at 
SPHC, targeting retired professionals.  
Moreover, she shared her learning in this 
program and the impact on her life.  She also 
highlighted some authors of the Book “At 
Ease with life & Death II”, who shared their 
unique perspective on life and death.  Each 
participant of the Forum received a copy of 
the new book.
Photo: Invited speakers answering questions 
from the floor.
晚情論壇 生死兩相安
Sponsorship recipient, Carol has gained 
valuable experience in the clinical placement at 
St. Christopher’s Hospice in England.
Attending a group art therapy for patients 
during Carol’s placement.
The sponsorship is open to medical practitioners, allied health professionals, and others for 
travelling aboard to engage in study and training in order to gain experience in palliative care. 
The insights and experience acquired could be adapted locally to enhance the quality of end of life 
care in Hong Kong. Sponsorship will be open for application twice a year around April and October. 
This application deadline is 31 October 2011. 
The mortuary at St. Christopher’s Hospice 
provides a supporting environment for the family to 
spend time with the deceased.
Dr. Kwok, another recipient shared her visit to 
Japan at 8th Hong Kong Palliative care Symposium.
Catherine, sponsorship recipient shared her learning 
on Narrative Therapy with participants at the Symposium. 
SPHC Sponsorship for 
Overseas Palliative care training
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